175 related articles for article (PubMed ID: 25749560)
1. The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B.
Coppola N; Zampino R; Bellini G; Stanzione M; Capoluongo N; Marrone A; Macera M; Pasquale G; Boemio A; Maione S; Adinolfi LE; Del Giudice EM; Sagnelli E; Rossi F
Clin Microbiol Infect; 2015 Jun; 21(6):609.e1-4. PubMed ID: 25749560
[TBL] [Abstract][Full Text] [Related]
2. Association between a polymorphism in cannabinoid receptor 2 and severe necroinflammation in patients with chronic hepatitis C.
Coppola N; Zampino R; Bellini G; Macera M; Marrone A; Pisaturo M; Boemio A; Nobili B; Pasquale G; Maione S; Adinolfi LE; Perrone L; Sagnelli E; Miraglia Del Giudice E; Rossi F
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):334-40. PubMed ID: 23707465
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients.
Sagnelli C; Uberti-Foppa C; Hasson H; Bellini G; Minichini C; Salpietro S; Messina E; Barbanotti D; Merli M; Punzo F; Coppola N; Lazzarin A; Sagnelli E; Rossi F
PLoS One; 2017; 12(7):e0181890. PubMed ID: 28759568
[TBL] [Abstract][Full Text] [Related]
4. In vivo evidence that the cannabinoid receptor 2-63 RR variant is associated with the acquisition and/or expansion of HIV infection.
Sagnelli C; Uberti-Foppa C; Hasson H; Bellini G; Minichini C; Salpietro S; Messina E; Barbanotti D; Merli M; Punzo F; Coppola N; Lazzarin A; Sagnelli E; Rossi F
HIV Med; 2018 Oct; 19(9):597-604. PubMed ID: 29932291
[TBL] [Abstract][Full Text] [Related]
5. Hepatic expression of cannabinoid receptors CB1 and CB2 correlate with fibrogenesis in patients with chronic hepatitis B.
Dai E; Zhang L; Ye L; Wan S; Feng L; Qi Q; Yao F; Li Z
Int J Infect Dis; 2017 Jun; 59():124-130. PubMed ID: 28315398
[TBL] [Abstract][Full Text] [Related]
6. Long-term lamivudine treatment achieves regression of advanced liver fibrosis/cirrhosis in patients with chronic hepatitis B.
Xu B; Lin L; Xu G; Zhuang Y; Guo Q; Liu Y; Wang H; Zhou X; Wu S; Bao S; Cai W; Xie Q
J Gastroenterol Hepatol; 2015 Feb; 30(2):372-8. PubMed ID: 25167956
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels.
Park JY; Park YN; Kim DY; Paik YH; Lee KS; Moon BS; Han KH; Chon CY; Ahn SH
J Viral Hepat; 2008 Aug; 15(8):615-21. PubMed ID: 18573162
[TBL] [Abstract][Full Text] [Related]
8. There were no differences in serum HBV DNA level between HBeAg-positive and HBeAg-negative chronic hepatitis B with same liver histological necroinflammation grade but differences among grades 1, 2, 3 and 4 apportioned by the same hepatic parenchyma cell volume.
Ke WM; Xie SB; Li XJ; Zhang SQ; Lai J; Ye YN; Gao ZL; Chen PJ
J Viral Hepat; 2011 Sep; 18(9):637-45. PubMed ID: 21794025
[TBL] [Abstract][Full Text] [Related]
9. CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection.
Coppola N; Zampino R; Bellini G; Stanzione M; Capoluongo N; Marrone A; Macera M; Adinolfi LE; Giudice EM; Gentile I; Sagnelli E; Rossi F
Dig Liver Dis; 2016 Nov; 48(11):1364-1369. PubMed ID: 27476469
[TBL] [Abstract][Full Text] [Related]
10. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients.
Karagoz E; Ulcay A; Tanoglu A; Kara M; Turhan V; Erdem H; Oncul O; Gorenek L
Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1320-4. PubMed ID: 25210777
[TBL] [Abstract][Full Text] [Related]
11. Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.
Hui CK; Leung N; Shek WH; Zhang HY; Luk JM; Poon RT; Lo CM; Fan ST; Lau GK;
J Clin Gastroenterol; 2008; 42(5):533-8. PubMed ID: 18344885
[TBL] [Abstract][Full Text] [Related]
12. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
[TBL] [Abstract][Full Text] [Related]
13. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.
Chang TT; Liaw YF; Wu SS; Schiff E; Han KH; Lai CL; Safadi R; Lee SS; Halota W; Goodman Z; Chi YC; Zhang H; Hindes R; Iloeje U; Beebe S; Kreter B
Hepatology; 2010 Sep; 52(3):886-93. PubMed ID: 20683932
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B.
Alam S; Ahmad N; Mustafa G; Shrestha A; Alam AK; Khan M
Liver Int; 2011 Jul; 31(6):824-30. PubMed ID: 21645213
[TBL] [Abstract][Full Text] [Related]
15. Viral load speaks little about toll on liver.
Mahtab MA; Rahman S; Khan M; Kamal M; Mamun AA; Karim MF
Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):483-6. PubMed ID: 17897910
[TBL] [Abstract][Full Text] [Related]
16. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
Yilmaz S; Bayan K; Tüzün Y; Dursun M; Kaplan A; Ozmen S; Canoruç F; Akkuş Z
Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C.
Coppola N; Zampino R; Sagnelli C; Bellini G; Marrone A; Stanzione M; Capoluongo N; Boemio A; Minichini C; Adinolfi LE; Maione S; Del Giudice EM; Sagnelli E; Rossi F
PLoS One; 2014; 9(6):e99450. PubMed ID: 24940753
[TBL] [Abstract][Full Text] [Related]
18. IL-18, TNF, and IFN-γ alleles and genotypes are associated with susceptibility to chronic hepatitis B infection and severity of liver injury.
Ferreira Sda C; Chachá SG; Souza FF; Teixeira AC; Santana Rde C; Deghaide NH; Rodrigues S; Marano LA; Mendes-Junior CT; Zucoloto S; Donadi EA; Martinelli Ade L
J Med Virol; 2015 Oct; 87(10):1689-96. PubMed ID: 25952099
[TBL] [Abstract][Full Text] [Related]
19. Effect of antiviral therapy on the immunohistochemical expression of bcl-xL and bax protein in patients with HBeAg-negative chronic hepatitis B.
Cholongitas E; Papatheodoridis GV; Manesis EK; Petraki K; Tiniakos D; Hadziyannis SJ
J Med Virol; 2011 Jul; 83(7):1165-71. PubMed ID: 21567420
[TBL] [Abstract][Full Text] [Related]
20. Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection.
Chan HL; Tsang SW; Liew CT; Tse CH; Wong ML; Ching JY; Leung NW; Tam JS; Sung JJ
Am J Gastroenterol; 2002 Feb; 97(2):406-12. PubMed ID: 11866280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
